.jpeg)
Antibiotic resistance isn’t a future crisis — it’s already here. From post-surgery infections that won’t heal to newborns dying of untreatable sepsis, India is quietly losing a battle most people don’t even know we’re fighting.
And now, there’s a glimmer of hope.
Mumbai-based Wockhardt’s new drug, Zaynich, has shown a 97% success rate against deadly, drug-resistant infections even ICUs fear. The kind of bugs that laugh at last-resort antibiotics like carbapenems.
Because in India, we’ve normalised popping antibiotics for every cold, fever, and sore throat. This reckless habit has bred superbugs, turning simple illnesses into fatal threats.
A Life Saved, A Lesson for Us
In the US, a 73-year-old woman defeated by an unstoppable infection was pulled back from the brink by Zaynich. That wasn’t a statistic. That was a life.
Zaynich isn’t just a medical win. It could mean that the next time someone you love lands in ICU, there’s still a drug left to try. A fighting chance in a war India’s been quietly losing.
The Bottom Line
We’ve treated antibiotics like toffees for too long. Zaynich is both a miracle and a wake-up call. One we can’t afford to ignore.